Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, continues to be a significant global health concern. This article presents an updated approach to its diagnosis and treatment, providing a comprehensive guide for healthcare professionals.
The gold standard for diagnosing enteric fever remains blood culture, despite its limitations in sensitivity. Molecular methods, such as Polymerase Chain Reaction (PCR), are emerging as promising tools due to their high sensitivity and specificity. However, these require specialized facilities and trained personnel. Serological tests, like the Widal test, can be useful in resource-limited settings, but their reliability is often questioned due to cross-reactivity.
Antibiotic therapy is the mainstay of treatment for enteric fever. Choice of antibiotic should be guided by local antimicrobial resistance patterns. Fluoroquinolones were once the first-line treatment but rising resistance has necessitated a shift towards third-generation cephalosporins and azithromycin. The role of vaccines in prevention should not be underestimated, especially in endemic areas.
Public health interventions play a crucial role in controlling enteric fever. These include access to clean water, improved sanitation, and food safety measures. In addition, surveillance systems can help monitor disease trends and antimicrobial resistance, guiding policy and practice.
Enteric fever remains a significant public health challenge requiring a multi-faceted approach. While diagnostic methods and treatment strategies continue to evolve, the importance of public health measures in disease control cannot be overstated. As healthcare professionals, staying abreast of these updates is crucial in delivering effective patient care and contributing to global health improvement.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation